LSU’s New Touch-Limiting Syringe Improves Stem Cell Delivery and Results for Patients

LSU researchers have invented a better syringe for delivering and injecting stem cells, allowing physicians and veterinarians to provide more effective treatment of tendon injuries by limiting the number of times the cells are "touched."

Dr. Mandi Lopez, director of the LSU School of Veterinary Medicine’s Laboratory for Equine and Comparative Orthopedic Research, has applied to patent the device through the LSU Office of Innovation & Technology Commercialization. If approved, it will be her eighth U.S. patent.

Keeping the cells or tissue alive and uncontaminated is a big hurdle, Lopez said. The device limits the number of times stem cells are handled, and potentially damaged, at the lab where they are grown, in transit, and during the medical procedure.

“Our researchers are scripting a narrative of healing, resilience and groundbreaking discoveries for a brighter and healthier Louisiana,” said Robert Twilley, LSU vice president of research and economic development.

Read More about the New Medical Device